Protein Technologies (PTL) is a world-leading innovator in protein technologies, offering a comprehensive range of products and services in the fields of recombinant proteins, protein engineering, biotherapeutics, biosensors, and bioreactors. With state-of-the-art laboratories located at Manchester Science Park in the United Kingdom, PTL is dedicated to delivering cutting-edge solutions. PTL provides contract cGMP manufacturing and research services to the biopharma industry, with a focus on rare and neglected diseases.

Their expertise lies in the development of effective diagnostic tools and therapies for these conditions. Additionally, PTL offers protein characterization services, allowing for analysis of protein folding, stability, and aggregation. With extensive process development capabilities, PTL ensures rapid progress of biologic candidates into production, offering robust, reproducible, and scalable solutions.

The company is known for its innovative gene-to-protein-to-cGMP services, which produce highly pure proteins in microgram to gram quantities. Established in 2010, Protein Technologies has received multiple awards and funding for its biotechnology innovation. Join them in their mission to revolutionize protein technologies and make a significant impact in the field of biopharma.

Contact PTL today to discover how their expertise can benefit your projects